
Krka Investor Relations Material
Latest events

Q1 2024
Krka

Q1 2025
16 May, 2025

H2 2024
10 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Krka d. d.
Access all reports
Krka, d. d., Novo mesto is a Slovenia-based international generic pharmaceutical company. The company focuses on the development, production, marketing, and sales of pharmaceutical products for human health, including prescription pharmaceuticals, self-medication products, and cosmetics. Additionally, Krka extends its product range to animal health products. With a presence in more than 70 countries, Krka has established production and distribution centers in key markets such as Russia, Poland, Croatia, and Germany, supporting its global distribution network. The company's commitment to quality and innovation has been instrumental in its expansion and ability to meet diverse health needs worldwide. The company is headquartered in Novo Mesto, Slovenia, and its shares are listed on the Warsaw Stock Exchange.
Key slides for Krka d. d.


Q4 2024
Krka d. d.


Q4 2024
Krka d. d.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
KRK
Country
🇸🇮 Slovenia